T. Tashiro

发表

Elderly onset age is associated with low efficacy of first anti-tumor necrosis factor treatment in patients with inflammatory bowel disease

S. Hiyama, Takuya Yamada, T. Takehara, 2022, Scientific Reports.

Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis

E. Morii, T. Mizushima, T. Takehara, 2021, World journal of gastroenterology.

Lysophosphatidylserines derived from microbiota in Crohn’s disease elicit pathological Th1 response

Y. Okada, K. Takeda, T. Takehara, 2022, The Journal of experimental medicine.

Exacerbation of non‐steroidal anti‐inflammatory drug‐induced enteropathy in C‐C chemokine receptor type 7‐deficient mice

T. Takehara, D. Motooka, Shota Nakamura, 2022, Journal of gastroenterology and hepatology.

Novel Mass Spectrometry-Based Comprehensive Lipidomic Analysis of Plasma from Patients with Inflammatory Bowel Disease.

T. Takehara, Takahiro Inoue, H. Iijima, 2020, Journal of gastroenterology and hepatology.

Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma

S. Hiyama, E. Morii, T. Mizushima, 2021, BMC cancer.

Use of a convolutional neural network for classifying microvessels of superficial esophageal squamous cell carcinomas

T. Takehara, H. Iijima, Y. Hayashi, 2021, Journal of gastroenterology and hepatology.

Seasonal variations in gut microbiota and disease course in patients with inflammatory bowel disease.

T. Takehara, D. Motooka, Takahiro Inoue, 2023, PloS one.

Carbon dioxide insufflation reduces the relapse of ulcerative colitis after colonoscopy: A randomized controlled trial

S. Hiyama, T. Takehara, H. Iijima, 2023, PloS one.